Sana Biotechnology, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sana Biotechnology, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Sana Biotechnology, Inc. Return On Equity for the quarter ending September 30, 2024 was -94.5 %, a 41.3% decline year-over-year.
  • Sana Biotechnology, Inc. annual Return On Equity for 2023 was -78.9 %, a 76.1% decline from 2022.
  • Sana Biotechnology, Inc. annual Return On Equity for 2022 was -44.8 %, a 5.29% decline from 2021.
  • Sana Biotechnology, Inc. annual Return On Equity for 2021 was -42.5 %, a 144% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -94.5 -27.6 -41.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -71.6 +6.66 +8.51% Apr 1, 2024 Jun 30, 2024
Q1 2024 -89.2 -29.2 -48.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -78.9 -34.1 -76.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -66.9 -21.4 -47% Jul 1, 2023 Sep 30, 2023
Q2 2023 -78.3 -37.2 -90.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -60 -33.9 -130% Jan 1, 2023 Mar 31, 2023
Q4 2022 -44.8 -2.25 -5.29% Oct 1, 2022 Dec 31, 2022
Q3 2022 -45.5 +19.8 +30.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -41.1 +82.7 +66.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -26.1 -1.58K -102% Jan 1, 2022 Mar 31, 2022
Q4 2021 -42.5 -140 -144% Oct 1, 2021 Dec 31, 2021
Q3 2021 -65.3 Jul 1, 2021 Sep 30, 2021
Q2 2021 -124 Apr 1, 2021 Jun 30, 2021
Q1 2021 1.56K Jan 1, 2021 Mar 31, 2021
Q4 2020 97.7 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.